Guglielmo Consales1, Elena Gramigni2, Lucia Zamidei3, Daniela Bettocchi2, Angelo Raffaele De Gaudio3. 1. Anaesthesia and Intensive Care Unit, Misericordia e Dolce Hospital, piazza dell'Ospedale 5, 59100 Prato, Italy. Electronic address: gconsales@gmail.com. 2. Anaesthesia and Intensive Care Unit, Misericordia e Dolce Hospital, piazza dell'Ospedale 5, 59100 Prato, Italy. 3. Section of Anaesthesia and Intensive Care, Department of Critical Care, University of Florence, Viale Morgagni 85, 50134 Firenze, Italy.
Abstract
PURPOSE: Multidrug-resistant Acinetobacter baumannii (MRAB) is an emerging cause of intensive care unit (ICU) outbreaks. Patients are the main reservoirs, inducing cross transmission. We describe an MRAB outbreak that occurred in the Prato Hospital ICU in June to August 2009. MATERIALS AND METHODS: The ICU consists of 2 separated 4-bed rooms (rooms A and B). The MRAB-positive patients were included in our study. During the outbreak, infection control measures were enhanced; patients and environmental screenings were performed. A 6-month follow-up was carried out. RESULTS: Four of 26 patients admitted during the outbreak were MRAB positive. All patients were located in room A; no case was detected in room B either in the hospital or during the follow-up. Management included closure to new admissions, reinforcement of infection control measures, patient and environmental screenings, discharge of room B MRAB-negative patients for at least 5 days after the first case identification. All isolates were carbapenems resistant and tigecycline and colistin susceptible. All patients received tigecycline: 2 were successfully treated, 1 died because of preexisting illness, and 1 developed resistance and recovered after colistin therapy. CONCLUSIONS: Enhanced infection control measures and adequate antibiotic strategy limited the outbreak. Tigecycline allowed rapid recovery. Nevertheless, resistance ensued; so colistin remained the only therapeutic option. However, pan-drug resistance has been reported.
PURPOSE: Multidrug-resistant Acinetobacter baumannii (MRAB) is an emerging cause of intensive care unit (ICU) outbreaks. Patients are the main reservoirs, inducing cross transmission. We describe an MRAB outbreak that occurred in the Prato Hospital ICU in June to August 2009. MATERIALS AND METHODS: The ICU consists of 2 separated 4-bed rooms (rooms A and B). The MRAB-positive patients were included in our study. During the outbreak, infection control measures were enhanced; patients and environmental screenings were performed. A 6-month follow-up was carried out. RESULTS: Four of 26 patients admitted during the outbreak were MRAB positive. All patients were located in room A; no case was detected in room B either in the hospital or during the follow-up. Management included closure to new admissions, reinforcement of infection control measures, patient and environmental screenings, discharge of room B MRAB-negative patients for at least 5 days after the first case identification. All isolates were carbapenems resistant and tigecycline and colistin susceptible. All patients received tigecycline: 2 were successfully treated, 1 died because of preexisting illness, and 1 developed resistance and recovered after colistin therapy. CONCLUSIONS: Enhanced infection control measures and adequate antibiotic strategy limited the outbreak. Tigecycline allowed rapid recovery. Nevertheless, resistance ensued; so colistin remained the only therapeutic option. However, pan-drug resistance has been reported.
Authors: Bartolome Moya; Isabel M Barcelo; Sachin Bhagwat; Mahesh Patel; German Bou; Krisztina M Papp-Wallace; Robert A Bonomo; Antonio Oliver Journal: Antimicrob Agents Chemother Date: 2017-10-24 Impact factor: 5.191
Authors: Madiha Fida; Scott A Cunningham; Stephan Beisken; Andreas E Posch; Nicholas Chia; Patricio R Jeraldo; Matthew P Murphy; Nicole M Zinsmaster; Robin Patel Journal: J Clin Microbiol Date: 2022-07-12 Impact factor: 11.677
Authors: D Timofte; M Dan; I E Maciuca; L Ciucu; E R Dabija; E Guguianu; C V Panzaru Journal: Eur J Clin Microbiol Infect Dis Date: 2015-08-04 Impact factor: 3.267
Authors: Marco Pignatti; Giorgio Enrico Gerunda; Gianluca Rompianesi; Nicola De Ruvo; Fabrizio Di Benedetto; Mauro Codeluppi; Decenzio Bonucchi; Lucrezia Pacchioni; Pietro Loschi; Cristina Malaventura; Giorgio De Santis Journal: Patient Saf Surg Date: 2013-09-03